- Home
- ZLAB vs VERA Comparison
ZLAB vs VERA Comparison
Compare ZLAB & VERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZLAB
- VERA
- Stock Information
- Founded
- ZLAB 2013
- VERA 2016
- Country
- ZLAB China
- VERA United States
- Employees
- ZLAB N/A
- VERA N/A
- Industry
- ZLAB Biotechnology: Pharmaceutical Preparations
- VERA Biotechnology: Pharmaceutical Preparations
- Sector
- ZLAB Health Care
- VERA Health Care
- Exchange
- ZLAB Nasdaq
- VERA Nasdaq
- Market Cap
- ZLAB 3.6B
- VERA 2.0B
- IPO Year
- ZLAB 2017
- VERA 2021
- Fundamental
- Price
- ZLAB $35.19
- VERA $23.20
- Analyst Decision
- ZLAB Buy
- VERA Buy
- Analyst Count
- ZLAB 5
- VERA 8
- Target Price
- ZLAB $54.28
- VERA $64.63
- AVG Volume (30 Days)
- ZLAB 689.4K
- VERA 1.3M
- Earning Date
- ZLAB 08-07-2025
- VERA 08-07-2025
- Dividend Yield
- ZLAB N/A
- VERA N/A
- EPS Growth
- ZLAB N/A
- VERA N/A
- EPS
- ZLAB N/A
- VERA N/A
- Revenue
- ZLAB $418,326,000.00
- VERA N/A
- Revenue This Year
- ZLAB $44.07
- VERA N/A
- Revenue Next Year
- ZLAB $49.13
- VERA N/A
- P/E Ratio
- ZLAB N/A
- VERA N/A
- Revenue Growth
- ZLAB 43.72
- VERA N/A
- 52 Week Low
- ZLAB $16.01
- VERA $18.53
- 52 Week High
- ZLAB $44.34
- VERA $51.61
- Technical
- Relative Strength Index (RSI)
- ZLAB 49.90
- VERA 49.75
- Support Level
- ZLAB $32.31
- VERA $22.57
- Resistance Level
- ZLAB $35.72
- VERA $24.58
- Average True Range (ATR)
- ZLAB 1.10
- VERA 1.13
- MACD
- ZLAB -0.34
- VERA 0.06
- Stochastic Oscillator
- ZLAB 60.17
- VERA 38.05
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.
About VERA Vera Therapeutics Inc.
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.